Patient's Preference Between Conventional Oral Olanzapine Tablet vs Olanzapine Orodispersible Tablet
Clinical trial NCT00324051 · COMPLETED
Trial details
- NCT number
- NCT00324051
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2007-09-01
- Enrollment
- 284
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.